Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-875 in Type 2 Diabetes Mellitus
NCT01433406Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Oct 2011; status: completed.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01433406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433406.